Targeted Oncology

Targeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes: Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches. Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways. Current Opinion articles that place interesting areas in perspective. Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations. Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement. Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.

《靶向肿瘤学》是所有致力于肿瘤学和癌症研究的医生和科学家的实用工具。 最近，对癌症遗传学和生物学的更好理解为该疾病的病理学和新的治疗策略提供了重要线索。 创新疗法，包括针对致癌途径和免疫检查点的小分子抑制剂和生物制剂已经出现，目前正在彻底改变我们治疗癌症患者的方式。尽管取得了这些突破，但在了解这些新化合物和识别治疗成功的标志方面仍有大量工作要做。 《靶向肿瘤学》重点关注分子靶向药物临床前和临床方面的原创研究文章，以及讨论临床已建立以及新兴药物和途径的综合叙述性评论文章。该杂志还发表了使用 PRISMA 声明中概述的明确、系统方法的系统评论，以及对肿瘤学中较新和成熟的靶向药物的特性和治疗地位的 Adis 药物评论。